» Articles » PMID: 35171361

Utility of Whole Exome Sequencing Analysis in Differentiating Intrapulmonary Metastatic Multiple Ground-glass Nodules (GGNs) from Multiple Primary GGNs

Overview
Specialty Oncology
Date 2022 Feb 16
PMID 35171361
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Clinical evidence of metastasis with ground-glass nodules (GGNs) has been reported, including pulmonary metastasis and distant metastasis. However, the clonal relationships of multiple GGNs at the genetic level remain unclear.

Experimental Design: Sixty tissue specimens were obtained from 19 patients with multiple GGN lung cancer who underwent surgery in 2019. Whole exome sequencing (WES) was performed on tissue samples, and genomic profiling and clone evolution analysis were conducted to investigate the genetic characteristics and clonality of multiple GGNs.

Results: A total of 15,435 nonsynonymous mutations were identified by WES, and GGNs with shared nonsynonymous mutations were observed in seven patients. Copy number variant (CNV) analysis showed that GGNs in ten patients had at least one shared arm-level CNV. Mutational spectrum analysis showed that GGNs in three patients had similar six substitution profiles and GGNs in fou patients had similar 96 substitution profiles. According to the clone evolution analysis, we found that GGNs in five patients had shared clonal driver gene mutations. Taken together, we identified that 5 patients may have multiple primary GGNs without any similar genetic features, 2 patients may have intrapulmonary metastatic GGNs with ≥ 3 similar genetic features, and the other 12 patients cannot be determined due to insufficient evidences in our cohort.

Conclusions: Our findings suggest that the intrapulmonary metastasis exist in multiple GGNs, but the number of GGNs was not associated with the probability of metastasis. Application of genomic profiling may prove to be important to precise management of patients with multiple GGNs.

Citing Articles

When multiple primary lung cancers express the same rare mutation: a case report.

Han Y, Geng Y, Sui Q, Liu Y, Xie S, Gao M Front Oncol. 2024; 14:1475193.

PMID: 39605888 PMC: 11598936. DOI: 10.3389/fonc.2024.1475193.


Diagnosis and management of multiple primary lung cancer.

Dong H, Tian Y, Xin S, Jiang S, Guo Y, Wan Z Front Oncol. 2024; 14:1392969.

PMID: 39411141 PMC: 11473257. DOI: 10.3389/fonc.2024.1392969.


Multidimensional biological characteristics of ground glass nodules.

Chen F, Li J, Li L, Tong L, Wang G, Zou X Front Oncol. 2024; 14:1380527.

PMID: 38841161 PMC: 11150621. DOI: 10.3389/fonc.2024.1380527.

References
1.
Detterbeck F, Marom E, Arenberg D, Franklin W, Nicholson A, Travis W . The IASLC Lung Cancer Staging Project: Background Data and Proposals for the Application of TNM Staging Rules to Lung Cancer Presenting as Multiple Nodules with Ground Glass or Lepidic Features or a Pneumonic Type of Involvement in the Forthcoming.... J Thorac Oncol. 2016; 11(5):666-680. DOI: 10.1016/j.jtho.2015.12.113. View

2.
Jamal-Hanjani M, Wilson G, McGranahan N, Birkbak N, Watkins T, Veeriah S . Tracking the Evolution of Non-Small-Cell Lung Cancer. N Engl J Med. 2017; 376(22):2109-2121. DOI: 10.1056/NEJMoa1616288. View

3.
Dalpiaz G, Asioli S, Fanti S, Rea G, Marchiori E . Rapidly growing pulmonary ground-glass nodule caused by metastatic melanoma lacking uptake on 18F-FDG PET-CT. J Bras Pneumol. 2018; 44(2):171-172. PMC: 6044662. DOI: 10.1590/s1806-37562017000000298. View

4.
Kim S, Lee S, Koh M, Lee I, Moon C, Jung S . Ground-glass opacity in lung metastasis from breast cancer: a case report. Tuberc Respir Dis (Seoul). 2013; 74(1):32-6. PMC: 3563701. DOI: 10.4046/trd.2013.74.1.32. View

5.
Chung J, Choe G, Jheon S, Sung S, Kim T, Lee K . Epidermal growth factor receptor mutation and pathologic-radiologic correlation between multiple lung nodules with ground-glass opacity differentiates multicentric origin from intrapulmonary spread. J Thorac Oncol. 2009; 4(12):1490-5. DOI: 10.1097/JTO.0b013e3181bc9731. View